Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:31 PM
Ignite Modification Date:
2025-12-25 @ 7:16 PM
NCT ID:
NCT01696032
Group ID:
EG001
Title:
Stage 1: Guadecitabine+Carboplatin 45 mg/m2
Description:
Guadecitabine 45 mg/m2 on Days 1-5 and carboplatin AUC 4 on Day 8 of 28-day treatment cycles. Due to dose limiting toxicities, the guadecitabine dose for this group was reduced from 45 mg/m2 to 30 mg/m2 after Cycle 1 for 4 of 6 participants and the carboplatin dose was reduced for 2 of 6 participants.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
6
Other Number Affected:
6
Other Number At Risk:
6
Study:
NCT01696032
Results Section:
NCT01696032
Adverse Events Module:
NCT01696032